Clinical trials
Phase 2/3 trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
87 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Recruiting | 17 |
| Terminated | 11 |
| Unknown status | 6 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 14 |
| Bristol-Myers Squibb | 4 |
| Pfizer | 4 |
| Haukeland University Hospital | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Boehringer Ingelheim | 2 |
| Facet Biotech | 2 |
| Norwegian University of Science and Technology | 2 |
| Sanofi | 2 |
| University Hospital of North Norway | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 4 |
| Neoplasms | 4 |
| Atherosclerosis | 2 |
| COVID-19 | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Diabetes Mellitus | 2 |
| Diabetic Foot | 2 |
| Glioblastoma | 2 |
| Lung Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 76 to 87 of 87. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.